Prenetics Global Limited (PRE)

NASDAQ: PRE · IEX Real-Time Price · USD
4.050
+0.480 (13.45%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Company Description

Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom.

Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use.

The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors.

It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes.

Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Prenetics Global Limited
Prenetics Global logo
Country Hong Kong
Founded 2014
Industry Diagnostics & Research
Sector Healthcare
Employees 400
CEO Sheng Wu Yeung

Contact Details

Address:
7/f, K11 Atelier, 728 King's Road
Quarry Bay, K3 000000
Hong Kong
Phone (852) 2210-7188
Website prenetics.com

Stock Details

Ticker Symbol PRE
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001876431
CUSIP Number G72245106
ISIN Number KYG722451229
SIC Code 3826

Key Executives

Name Position
Sheng Wu Yeung Co-Founder and Chief Executive Officer
Dr. Chi Hung Tzang Ph.D. Co-Founder, Chief Scientific Officer and Member of Scientific Advisory Board
Hoi Chun Lo Chief Financial Officer
Dr. Yung Ho Wong DPHIL Chief Technology Officer
Yvonne L. Wong Chief Corporate Development Officer
Samantha Kwok Vice President People and Culture
Dr. Senthil Sundaram M.D. Chief Clinical Officer
Avrom Boris Lasarow Chief Executive Officer of EMEA
Dr. Shih-Chang Ong M.D. Chief Medical Officer and Member of Scientific Advisory Board
Joel Neoh Chief Consumer Officer and MD for CircleDNA

Latest SEC Filings

Date Type Title
Feb 16, 2024 EFFECT Notice of Effectiveness
Feb 16, 2024 424B3 Prospectus
Feb 5, 2024 F-3/A Filing
Feb 5, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 26, 2024 UPLOAD Filing
Jan 17, 2024 F-3 Filing
Nov 30, 2023 6-K Report of foreign issuer
Nov 27, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 20, 2023 6-K Report of foreign issuer
Nov 13, 2023 6-K Report of foreign issuer